1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Urological conditions
  5. Lower urinary tract symptoms

iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia

Medtech innovation briefing [MIB306] Published: 21 September 2022

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

iTind is a CE marked class IIa medical device.


  • Next